These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19052708)

  • 1. [Opioid-induced bowel dysfunction: a literature analysis on pathophysiology and treatment].
    Osterbrink J; Haas U
    Wien Med Wochenschr; 2008; 158(21-22):621-6. PubMed ID: 19052708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid-induced constipation.
    Wein S
    J Pain Palliat Care Pharmacother; 2012 Dec; 26(4):382-4. PubMed ID: 23216186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of opioid-induced constipation.
    Prichard D; Norton C; Bharucha AE
    Br J Nurs; 2016 May 26-Jun 8; 25(10):S4-5, S8-11. PubMed ID: 27231750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review with meta-analysis: efficacy and safety of treatments for opioid-induced constipation.
    Vijayvargiya P; Camilleri M; Vijayvargiya P; Erwin P; Murad MH
    Aliment Pharmacol Ther; 2020 Jul; 52(1):37-53. PubMed ID: 32462777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylnaltrexone for opioid-induced constipation in advanced illness.
    Thomas J; Karver S; Cooney GA; Chamberlain BH; Watt CK; Slatkin NE; Stambler N; Kremer AB; Israel RJ
    N Engl J Med; 2008 May; 358(22):2332-43. PubMed ID: 18509120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological Treatment of Opioid-Induced Constipation Is Effective but Choice of Endpoints Affects the Therapeutic Gain.
    Nusrat S; Syed T; Saleem R; Clifton S; Bielefeldt K
    Dig Dis Sci; 2019 Jan; 64(1):39-49. PubMed ID: 30284134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylnaltrexone: a novel approach for the management of opioid-induced constipation in patients with advanced illness.
    Diego L; Atayee R; Helmons P; von Gunten CF
    Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):473-85. PubMed ID: 19817669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of opioid receptor antagonists in the treatment of opioid-induced constipation: a review.
    Leppert W
    Adv Ther; 2010 Oct; 27(10):714-30. PubMed ID: 20799006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylnaltrexone for opioid-induced constipation in advanced illness.
    Sanz Rubiales A; del Valle Rivero ML
    N Engl J Med; 2008 Sep; 359(10):1070-1; author reply 1071. PubMed ID: 18768955
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-analgesic effects of opioids: management of opioid-induced constipation by peripheral opioid receptor antagonists: prevention or withdrawal?
    Holzer P
    Curr Pharm Des; 2012; 18(37):6010-20. PubMed ID: 22747544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylnaltrexone bromide: new drug for the treatment of opioid-induced bowel dysfunction.
    Baker DE
    Rev Gastroenterol Disord; 2009; 9(3):E84-93. PubMed ID: 19898269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid-lnduced Constipation (OIC) Clinical Decision Support Tool.
    American Gastroenterological Association
    Gastroenterology; 2019 Jan; 156(1):227. PubMed ID: 30389392
    [No Abstract]   [Full Text] [Related]  

  • 13. Methylnaltrexone for opioid-induced constipation in advanced illness.
    Chappell D; Rehm M; Conzen P
    N Engl J Med; 2008 Sep; 359(10):1071; author reply 1071. PubMed ID: 18777614
    [No Abstract]   [Full Text] [Related]  

  • 14. Opioid-Induced Constipation (OIC) Guideline.
    Crockett S; Greer KB; Sultan S
    Gastroenterology; 2019 Jan; 156(1):228. PubMed ID: 30389393
    [No Abstract]   [Full Text] [Related]  

  • 15. Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness.
    Chamberlain BH; Cross K; Winston JL; Thomas J; Wang W; Su C; Israel RJ
    J Pain Symptom Manage; 2009 Nov; 38(5):683-90. PubMed ID: 19713070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. American Gastroenterological Association Institute Technical Review on the Medical Management of Opioid-Induced Constipation.
    Hanson B; Siddique SM; Scarlett Y; Sultan S;
    Gastroenterology; 2019 Jan; 156(1):229-253.e5. PubMed ID: 30337104
    [No Abstract]   [Full Text] [Related]  

  • 17. Targeted Novel Pharmacotherapy to Improve Outcomes in Opioid-Induced Constipation.
    Gupta A
    J Fam Pract; 2015 Nov; 64(11 Suppl 2):. PubMed ID: 26697546
    [No Abstract]   [Full Text] [Related]  

  • 18. American Gastroenterological Association Institute Guideline on the Medical Management of Opioid-Induced Constipation.
    Crockett SD; Greer KB; Heidelbaugh JJ; Falck-Ytter Y; Hanson BJ; Sultan S;
    Gastroenterology; 2019 Jan; 156(1):218-226. PubMed ID: 30340754
    [No Abstract]   [Full Text] [Related]  

  • 19. Opioid-Related Constipation.
    Liu JJ; Brenner DM
    Gastroenterol Clin North Am; 2022 Mar; 51(1):107-121. PubMed ID: 35135657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylnaltrexone for the Treatment of Constipation in Critically Ill Children.
    López J; Fernández SN; Santiago MJ; Urbano J; González R; Fernández-Llamazares C; López-Herce J
    J Clin Gastroenterol; 2016 Apr; 50(4):351-2. PubMed ID: 26950234
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.